Skip to main content

Electronic Skin Patches Ensure Early Diagnosis through Remote Monitoring

 

An electronic skin patch is a wearable device which adheres to the skin. It is a stick-on patch which can be worn on the body and is capable of collecting, monitoring and transmitting various health metrics such as respiration, temperature, blood glucose, blood pressure, and heartbeat to a smartphone, wirelessly. At present there are three major types of skin patches available in the market, including transdermal patches (drug delivery through skin), remote monitoring (patient vitals and blood glucose), and bioelectric stimulation (chronic pain management).

The electronic component of the electronic skin patch includes the electronic functionality including actuators, processors, sensors, and communication, permitting the device to be linked with other devices.

The electronic skin patch is ultra-thin and flexible, and designed for next-generation information for communication with the help of microelectronics and sensors by revealing  data about body temperature, UV radiation absorption, and blood oxygen levels. It is also used for drug delivery and therapeutic interventions. It can help in reducing the healthcare cost by decreasing hospital re-admission, reducing medication non-adherence, and increasing wellness management with connected smart devices and wearables to gather and evaluate medical data.

According to the market intelligence published by BIS Research, titled “Global Electronic Skin Patches Market - Analysis and Forecast, 2019-2024”, the electronic skin patches market generated a revenue of $3,899.1 million and is projected to grow at a CAGR of 17.22% during the forecast period from 2019 to 2024.

The growth of the market is driven by factors including the growing geriatric population that leads to a surge in exigency of electronic skin patches, increasing burden of chronic and lifestyle-associated diseases elevating the requirement of continuous monitoring and treatment of diseases, increasing inclination of people toward personal health and fitness, and growing prominence for point-of-care technologies, among others.

Electronic skin patches offer several benefits, including chronic disease management through initial intervention, promotion of a healthy lifestyle, early diagnosis through remote monitoring, enhanced transparency and patient independence, remote monitoring and self-managed care, and is an inexpensive and disposable technology.

The global electronic skin patches market entails several large-scale as well as small-scale manufacturers. Currently, the manufacturers in the market have ample opportunities to expand their services and to earn significant revenues. Some of the strategies followed by the manufacturers are product approvals, launches, joint ventures, agreements, collaborations, partnerships, mergers and acquisitions, and business expansions.

Some of these major players operating in the market include Abbott Laboratories, BioTelemetry, Inc., DexCom, Inc., General Electric Company, Insulet Corporation, iRhythm Technologies, Inc., Koninklijke Philips N.V., LifeSignals, Medtronic, Plc., MC10, Inc., Omron Corporation, VivaLNK, and VitalConnect.

Comments

Popular posts from this blog

Farm Management Software and Data Analytics Market Future Prospects And Competitive Analysis 2020-2026

The growth in the global farm management software and data analytics market is expected to be driven by increasing demand for agricultural mechanization and automation along with increasing average farm size in certain countries such as Australia and Canada. Report Preview is available at: https://bisresearch.com/industry-report/global-farm-management-software-data-analytics-market.html Farm management software and data analytic solutions not only offer increased transparency in the agricultural field but also decrease the chances of pest attack and crop failure. Increased agricultural production will help in catering to the growing population and uplifting the global agricultural industry. A major factor driving the farm management software and data analytics market is the increase in government initiatives and support toward agricultural digitization. Government initiatives increase the awareness regarding the farm management software and the benefits these solutions entail when appl...

Intelligent Lighting Controls Market Report

The report constitutes an extensive study of intelligent lighting controls market. It includes a thorough analysis of different component types as well as different connection types used in the intelligent lighting controls. Intelligent lighting controls market has further been segmented in terms of application which helps in understanding the behavior of different verticals in using intelligent lighting controls. It further explains the driving forces, challenges and growth opportunities of the intelligent lighting controls market. Major players have been identified on the basis of revenue generation, geographical presence and developments related to intelligent lighting controls. A detailed company profiling has been done in order to understand the player’s strategic behavior. The intelligent lighting controls market is further explained and analyzed on the basis of geography. The geographical analysis has been categorized into four regions namely: North America, Europe, Asia-Pa...

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...